IMPROVING CARDIORESPIRATORY PERFORMANCE IN DMD VIA COMBINATORIAL DYSTROPHIN AND RIBONUCLEOTIDE REDUCTASE GENE THERAPY
$1,119,658FY2018Defense Health AgencyDOD
University Of Washington, Seattle WA
Investigators
View source on USAspending →IMPROVING CARDIORESPIRATORY PERFORMANCE IN DMD VIA COMBINATORIAL DYSTROPHIN AND RIBONUCLEOTIDE REDUCTASE GENE THERAPY · GrantIndex